BGM Group Ltd. SEC filings BGM

BGM Group Ltd. has 154 filings in SEC EDGAR's recent list, going back to Jun 17, 2019. Its latest annual report, Form 20-F, was filed on Jul 21, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Sep 24, 2026. The company's fiscal year ends on September 30.

BGM Group Ltd. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 24, 2026 Sep 24, 2026
6-K Current report (foreign issuer) Sep 8, 2026 Sep 8, 2026
6-K Current report (foreign issuer) Aug 28, 2026 Aug 28, 2026
6-K Current report (foreign issuer) Aug 11, 2026 Aug 11, 2026
6-K Current report (foreign issuer) Jul 30, 2026 Jul 30, 2026
6-K Current report (foreign issuer) Jul 28, 2026 Jul 28, 2026
6-K Current report (foreign issuer) Jul 13, 2026 Jul 13, 2026
6-K Current report (foreign issuer) Jun 17, 2026 Jun 17, 2026
6-K Current report (foreign issuer) Jun 9, 2026 Jun 9, 2026
6-K Current report (foreign issuer) May 18, 2026 May 18, 2026
6-K Current report (foreign issuer) May 7, 2026 May 7, 2026
6-K Current report (foreign issuer) Apr 30, 2026 Apr 30, 2026
6-K Current report (foreign issuer) Jan 29, 2026 Jan 29, 2026
6-K Current report (foreign issuer) Dec 22, 2025 Dec 18, 2025
6-K Current report (foreign issuer) Aug 14, 2025 Aug 14, 2025
6-K Current report (foreign issuer) Jul 24, 2025 Mar 31, 2025
6-K Current report (foreign issuer) Jun 26, 2025 Jun 26, 2025
6-K Current report (foreign issuer) May 28, 2025 May 28, 2025
6-K Current report (foreign issuer) May 20, 2025 May 20, 2025
6-K Current report (foreign issuer) May 6, 2025 May 6, 2025
6-K Current report (foreign issuer) Apr 28, 2025 Apr 28, 2025
6-K Current report (foreign issuer) Apr 22, 2025 Apr 22, 2025
6-K Current report (foreign issuer) Mar 28, 2025 Mar 28, 2025
6-K Current report (foreign issuer) Mar 19, 2025 Mar 19, 2025
6-K Current report (foreign issuer) Feb 28, 2025 Feb 28, 2025
6-K Current report (foreign issuer) Jan 7, 2025 Jan 7, 2025
6-K Current report (foreign issuer) Nov 29, 2024 Nov 29, 2024
6-K Current report (foreign issuer) Nov 27, 2024 Nov 27, 2024
6-K Current report (foreign issuer) Oct 22, 2024 Oct 22, 2024
6-K/A Form 6-k/a Oct 10, 2024 Oct 10, 2024
6-K Current report (foreign issuer) Sep 9, 2024 Sep 9, 2024
6-K Current report (foreign issuer) Aug 14, 2024 Mar 31, 2024
6-K Current report (foreign issuer) Jun 6, 2024 Jun 6, 2024
6-K Current report (foreign issuer) Jun 4, 2024 Jun 3, 2024
6-K Current report (foreign issuer) Apr 25, 2024 Apr 25, 2024
6-K Current report (foreign issuer) Mar 11, 2024 Mar 11, 2024
6-K Current report (foreign issuer) Dec 20, 2023 Dec 19, 2023
6-K Current report (foreign issuer) Dec 7, 2023 Dec 7, 2023
6-K Current report (foreign issuer) Oct 31, 2023 Oct 31, 2023
6-K Current report (foreign issuer) Aug 4, 2023 Aug 4, 2023
6-K Current report (foreign issuer) Jul 25, 2023 Jul 25, 2023
6-K Current report (foreign issuer) Jun 14, 2023 Jun 14, 2023
6-K Current report (foreign issuer) Apr 26, 2023 Apr 26, 2023
6-K Current report (foreign issuer) Feb 23, 2023 Feb 23, 2023
6-K Current report (foreign issuer) Feb 16, 2023 Feb 16, 2023
6-K Current report (foreign issuer) Jan 10, 2023 Jan 10, 2023
6-K Current report (foreign issuer) Dec 7, 2022 Dec 7, 2022
6-K Current report (foreign issuer) Nov 17, 2022 Nov 17, 2022
6-K Current report (foreign issuer) Oct 4, 2022 Oct 4, 2022
6-K Current report (foreign issuer) Sep 30, 2022 Sep 30, 2022
6-K Current report (foreign issuer) Aug 29, 2022 Aug 29, 2022
6-K Current report (foreign issuer) Apr 15, 2022 Apr 15, 2022
6-K Current report (foreign issuer) Feb 11, 2022 Feb 11, 2022
6-K Current report (foreign issuer) Sep 16, 2021 Sep 9, 2021
6-K Current report (foreign issuer) Feb 11, 2021 Feb 11, 2021
6-K Current report (foreign issuer) Jan 20, 2021 Jan 20, 2021
6-K Current report (foreign issuer) Jan 15, 2021 Jan 15, 2021

Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BGM (Nasdaq)
Fiscal year ends
September 30
Incorporated in
Cayman Islands
Headquarters
Chengdu
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1779578
Former names
Qilian International Holding Group (until Oct 22, 2024); Qilian International Holding Group Ltd (until Oct 16, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.